Skip to main content
Addgene

pCR2.1_HBB_A
(Plasmid #87848)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 87848 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pCR2.1-TOPO
  • Backbone manufacturer
    Invitrogen (Life Technologies)
  • Backbone size w/o insert (bp) 3930
  • Total vector size (bp) 4256
  • Vector type
    Bacterial Expression
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin and Kanamycin, 100 & 50 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Homo sapiens hemoglobin subunit beta (HBB), Aberrant cDNA fragment (Exon1/19nt mispliced Intron1 + Exon2)
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    329
  • Mutation
    HBB(IVSI-110) β-thalassaemia misplicing mutation (HGVS name: HBB:c.93-21G>A)
  • GenBank ID
    NM_000518.4
  • Entrez Gene
    HBB (a.k.a. CD113t-C, ECYT6, beta-globin)

Cloning Information

  • Cloning method TOPO Cloning
  • 5′ sequencing primer M13 Reverse Primer
  • 3′ sequencing primer M13 Forward Primer
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCR2.1_HBB_A was a gift from Marina Kleanthous (Addgene plasmid # 87848 ; http://n2t.net/addgene:87848 ; RRID:Addgene_87848)
  • For your References section:

    Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI-110 (G > A)) beta-Thalassemia. Patsali P, Papasavva P, Christou S, Sitarou M, Antoniou MN, Lederer CW, Kleanthous M. Int J Mol Sci. 2020 Sep 11;21(18). pii: ijms21186671. doi: 10.3390/ijms21186671. 10.3390/ijms21186671 PubMed 32933098